An Analytical Technique for Identifying Tribromoanisole - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

An Analytical Technique for Identifying Tribromoanisole
Combining olfactometry analysis with multidimensional gas chromatography–mass spectrometry provides an extremely useful analytical method for identifying aroma or odor notes from a sample.


Pharmaceutical Technology
pp. s10-s14

References

1. P. Kavilanz, "Tylenol Recall: FDA Slams Company," http://www.money.cnn.com/2010/01/15/news/companies/over_the_counter_medicine_recall/index.htm, accessed Oct. 3, 2011.

2. D.J. DeNoon, "Lipitor Recall Grows by 19,000 Bottles," http://www.webmd.com/cholesterol-management/news/20101221/lipitor-recall-grows-by-19000-bottles, accessed Oct. 3, 2011.

3. Reuters, "UPDATE 2-Depomed Recalls 52 Lots of Diabetes Drug," http://www.reuters.com/article/2010/06/17/depomed-idUSSGE65G0D020100617, accessed Oct. 3, 2011.

4. P. Van Arnum, ePT, May 19, 2011, http://www.pharmtech.findpharma.com/pharmtech/News/JampJ-to-Recall-Select-Lots-of-Prezista-Due-to-Pos/ArticleStandard/Article/detail/723176, accessed Oct. 3, 2011.

5. FiercePharma, "Depomed Recalls Diabetes Med on TBA Contamination," June 17, 2010, http://www.fiercepharma.com/story/depomed-recalls-diabetes-med-tba-contamination/2010-06-17, accessed Oct. 3, 2011.

6. F.B. Whitfield, J.L. Hill, and K.J. Shaw, J. Agric. Food Chem. 45 (3), 889–893 (1997).

7. P. Chatonnet et al., J. Agric. Food Chem. 52 (5), 1255–1262 (2004).

8. C. Pizarro, N. Perez-del-Notario, and J.M. Gonzales-Saiz, J. Chromatogr. A 1143 (1–2), 26–35 (2007).

9. P. Tomboulian et al., Water Sci. Technol. 49 (9), 219–226 (2004).

10. Weifang Huitao Chemical, "2,4,6-Tribromophenol (TBP)," (Weifang City, China), http://www.huitaotech.com/huitaotechcom/cpshow.asp?id=147&lxid=0005&gclid=CI3g8IWO8KsCFaJgTAodOxlSKA, accessed Oct. 17, 2011.

11. M. Foley and C. Brindley, Pallet Enterprise, Aug. 1, 2011, http://www.palletenterprise.com/articledatabase/view.asp?articleID=3457, accessed Oct. 17, 2011.

12. T.J. Evans, C.E.Butzke, and S.E. Ebeler, J. Chromatogr. A 786 (2), 293–298 (1977).

13. A. Diaz, F. Ventura, and M.T. Galceran, J. Chromatogr. A 1064 (1), 97–106 (2005).

14. E.Martendal et al., Mikrochim. Acta 159 (3–4), 229–234 (2007).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here